StockData
STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Stereotaxis, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.01+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$101.03M
P/E (TTM)
–
Dividend yield
–

Stereotaxis, Inc. balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
55.6%
Operating margin
-75.7%
Net margin
-74.2%
Return on equity, FY2025
-221.3%

Financial strength

Current ratio
1.42
Debt to equity
–
Debt to assets
–
Cash to current liabilities
39.1%

Valuation

P/E ratio
–
Price to sales
3.36
Price to book
8.25
Dividend yield
–